Before testing the efficacy of anti-HER2 CAR-T cells together with anti-PD1 antibody against breast cancer cells, we checked the expression of PDL1 on both 4T1 and 4T1-Luc-HER2 cells. The gene discussed is ERBB2; the disease is breast carcinoma.